CRLVSGTBP• 3 Months (Normalized)
CRL vs GTBP (Charles River Laboratories International Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CRL Performance $290.19
+26.9%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
GTBP Performance $6.1
+1226.09%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1199.19 pts
GTBP outperforming by 1199.19 percentage points
CRLGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CRL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | CRL Price | CRL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $290.19 | +26.90% | $6.10 | +1226.09% | -1199.19% |
| Oct 01, 2026 | $286.83 | +25.43% | $- | - | |
| Sep 30, 2026 | $295.01 | +29.01% | $- | - | |
| Sep 29, 2026 | $295.96 | +29.42% | $6.88 | +1394.57% | -1365.15% |
| Sep 28, 2026 | $294.59 | +28.82% | $6.80 | +1378.26% | -1349.44% |
| Sep 25, 2026 | $292.84 | +28.06% | $6.89 | +1397.83% | -1369.77% |
| Sep 24, 2026 | $- | $6.83 | +1384.78% | - | |
| Sep 23, 2026 | $277.33 | +21.27% | $7.10 | +1443.48% | -1422.21% |
| Sep 22, 2026 | $285.11 | +24.68% | $- | - | |
| Sep 21, 2026 | $279.01 | +22.01% | $7.18 | +1460.87% | -1438.86% |
| Sep 18, 2026 | $278.06 | +21.59% | $7.16 | +1456.52% | -1434.93% |
| Sep 17, 2026 | $281.67 | +23.17% | $7.49 | +1528.26% | -1505.09% |
| Sep 16, 2026 | $273.41 | +19.56% | $7.81 | +1597.83% | -1578.27% |
| Sep 15, 2026 | $272.88 | +19.33% | $9.00 | +1856.52% | -1837.19% |
| Sep 14, 2026 | $273.11 | +19.43% | $11.63 | +2428.26% | -2408.83% |
Page 1 of 5